)
)
Biohaven Investor Relations Material
Latest events
R&D Day 2024
Biohaven
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Biohaven Ltd
Access all reports
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. The company's product candidates are either in various stages of clinical trials or pre-clinical trials.
Key slides for Biohaven Ltd
Corporate Presentation
Biohaven Ltd
Corporate Presentation
Biohaven Ltd
Latest articles
)
ASML: Architecting Earth's Most Complex Machines
Discover how ASML, once seen as a struggling "problem child", grew into a global niche monopoly within advanced chip manufacturing equipment.
27 Sep 2024
)
Europastry: Ready Baked for IPO
Frozen bakery company Europastry is preparing for a potential IPO with reports suggesting that it is looking to enter the public markets in October.
27 Sep 2024
)
Haviv Ilan: CEO of Texas Instruments
Haviv Ilan was named CEO of Texas Instruments in 2023, following more than two decades of leadership across different roles at the U.S. company.
25 Sep 2024
Ticker symbol
BHVN
Country
🇺🇸 United States